Properties (59)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Research_Institute
|
| gptkbp:aimsTo |
Improve Drug Efficacy
Address Unmet Medical Needs Enhance Drug Delivery Facilitate Drug Approval Process Reduce Drug Development Time |
| gptkbp:collaboratesWith |
Universities
|
| gptkbp:conducts |
Clinical Trials
Safety Assessments Genomic Studies Preclinical Studies |
| gptkbp:conductsResearchOn |
Medicinal Chemistry
|
| gptkbp:contributedTo |
Public Health
|
| gptkbp:develops |
Therapeutics
New Drugs |
| gptkbp:employs |
Scientists
|
| gptkbp:engagesIn |
Collaborative Research
Drug Screening |
| gptkbp:focusesOn |
Target Identification
Pharmaceutical_Research |
| gptkbp:hasAccessTo |
Advanced_Technologies
|
| gptkbp:hasCollaborationsWith |
Industry Partners
Non-Profit_Organizations |
| gptkbp:hasEstablished |
Partnerships
Research Programs |
| gptkbp:hasLocation |
Various Locations
|
| gptkbp:historicalResearch |
Drug Mechanisms
|
| gptkbp:hosts |
Conferences
|
| https://www.w3.org/2000/01/rdf-schema#label |
Center for Drug Discovery
|
| gptkbp:isDedicatedTo |
Drug Innovation
|
| gptkbp:isEngagedIn |
Basic Research
Ethical Research Practices |
| gptkbp:isFocusedOn |
Infectious Diseases
Chronic Diseases Rare Diseases Oncology Research |
| gptkbp:isInvolvedIn |
Vaccine Development
Regulatory Affairs Patient Advocacy Drug Repurposing Patient-Centric Research Regenerative_Medicine Health_Policy_Research Neuroscience_Research Clinical_Research_Trials Biomarker_Discovery Pharmacogenomics_Research |
| gptkbp:isPartOf |
Academic Institutions
|
| gptkbp:isRecognizedFor |
Innovative_Research
|
| gptkbp:isSupportedBy |
Research Grants
Philanthropic Donations |
| gptkbp:offers |
Internships
|
| gptkbp:partnerships |
Pharmaceutical Companies
|
| gptkbp:provides |
Training Programs
Consulting_Services |
| gptkbp:receivesFundingFrom |
Government Grants
|
| gptkbp:supports |
Translational Medicine
|
| gptkbp:utilizes |
Biotechnology
Computational Biology |